What is a drug substance? Raw materials are the core ingredients of pharmaceutical companies in the pharmaceutical process, and pharmaceutical raw materials are divided into API (active pharmaceutical ingredients) and excipients (inactive pharmaceutical ingredients). High-quality raw materials can ensure the accuracy and safety of the results in the process of experiment and industrial production. Changzhou Wisdomdrug summarizes the importance of high-quality raw materials for pharmaceutical companies for you.
All drugs need to be approved by the national CFDA before entering the market, so clear drug raw materials and preparation processes can better identify and solve problems, and can pass compliance tests more quickly.
Pure, unadulterated drugs can reduce experimental errors, so it is also important to check the product list before production experiments. The operation of drug experiments is complex, and the possibility of mistakes should be reduced as far as possible, because the final effect of drugs is different in the population, and only after a clear understanding of its characteristics in human treatment, efficacy and side effects can we accurately grasp the efficacy of the final product in clinical application.
Wisdomdrug Pharmaceutical intermediates believes that the importance of ensuring the quality of pharmaceutical raw materials for the safe production of drugs is self-evident for pharmaceutical companies. Therefore, starting from the inspection of the purchase and storage of drugs, there should be no half a minute of carelessness, after all, a small mistake can lead to huge economic and brand reputation losses.
Wisdomdrug Pharmaceutical intermediates reprint this article based on the purpose of sharing industry information, does not mean that our company supports the views stated in the article, nor is responsible for the authenticity of the full text, if there is infringement, please contact us to delete.
About Wisdom Drugs
Wisdom Drugs Co .,Ltd was founded in Sep. 2011 whose headquarter located in Changzhou Creative Industry Park, having a branch in India. The company’s R&D center is engaged in not only the process development of APIs, intermediates, poly-peptide compounds and heterocyclic compounds,but also the optimization and production. We are devoted to the synthesis customization and the technology transfer, enabling compounds to be scaled from laboratory to commercial to meet the requirements of different customers.
